Skip to main content
Open
Question
Forecasts
Track record
Unknowns
How it works
Sources
FAQ
Menu
← Evidence map
Article
Nature biotechnology
2026
Engineering macrophage-targeted trispecific immune cell engagers for tumor immunotherapy.
PubMed ↗
Publisher ↗
No numbers read from the abstract.
Not cited yet
Engineering macrophage-targeted trispecific immune cell engagers for tumor immunotherapy. | OpenQuestion